Fractalkine expression in human renal inflammation

被引:106
作者
Cockwell, P [1 ]
Chakravorty, SJ
Girdlestone, J
Savage, COS
机构
[1] Univ Birmingham, Sch Med, Div Med Sci, Dept Renal Immunobiol, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Med, Dept Anat, Div Med Sci, Birmingham, W Midlands, England
关键词
fractalkine; kidney; vasculitis; allograft rejection; epithelial cells;
D O I
10.1002/path.1010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune and inflammatory human renal disease is associated with heavy mononuclear cell infiltration. The trafficking of these cells to extravascular sites is directed by local production of chemokines. Fractalkine is the first described cell-surface anchored chemokine and has potent mononuclear cell-directed adhesion and chemotactic properties. The purpose of this study was to analyse the expression and distribution of fractalkine in human renal inflammation. In situ hybridization and immunohistochemistry were used to study renal biopsies from 15 patients with predominant glomerular inflammation (vasculitic glomerulonephritis) and 15 with predominant tubular and interstitial inflammation (acute renal allograft rejection). Controls comprised noninflammatory glomerulonephritis. and normal tissue. Fractalkine mRNA was predominantly expressed in the major compartment, glomerular or tubulointerstitial, affected by disease and with the strongest expression localized to vascular sites local to inflammation. In acute renal allograft rejection, there was increased expression of fractalkine mRNA by tubular epithelia] cells. There was no expression of fractalkine by infiltrating leukocytes and there was only sparse expression in control tissue. Fractalkine mRNA expression correlated with infiltrating leukocyte subsets. Immunohistochemistry confirmed this pattern of expression, with serial section co-localization showing fractalkine expression in areas with macrophage (CD68+) and T cell (CD3+) infiltrates. These expression patterns show that fractalkine is a strong candidate for directing mononuclear cell infiltration in human renal inflammation. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 24 条
  • [1] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [2] A new class of membrane-bound chemokine with a CX(3)C motif
    Bazan, JF
    Bacon, KB
    Hardiman, G
    Wang, W
    Soo, K
    Rossi, D
    Greaves, DR
    Zlotnik, A
    Schall, TJ
    [J]. NATURE, 1997, 385 (6617) : 640 - 644
  • [3] T-CELLS AND MACROPHAGES IN RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS - CLINICOPATHOLOGICAL CORRELATIONS
    BOLTON, WK
    INNES, DJ
    STURGILL, BC
    KAISER, DL
    [J]. KIDNEY INTERNATIONAL, 1987, 32 (06) : 869 - 876
  • [4] In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II
    Chen, SH
    Bacon, KB
    Li, L
    Garcia, GE
    Xia, YY
    Lo, D
    Thompson, DA
    Siani, MA
    Yamamoto, T
    Harrison, JK
    Feng, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) : 193 - 198
  • [5] Chemokines and their receptors in leukocyte trafficking and renal inflammation
    Cockwell, P
    Savage, COS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1307 - 1310
  • [6] In situ analysis of C-C chemokine mRNA in human glomerulonephritis
    Cockwell, P
    Howie, AJ
    Adu, D
    Savage, COS
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (03) : 827 - 836
  • [7] Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 -: Rapid communication
    Feng, LL
    Chen, SZ
    Garcia, GE
    Xia, YY
    Siani, MA
    Botti, P
    Wilson, CB
    Harrison, JK
    Bacon, KB
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (02) : 612 - 620
  • [8] Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow
    Fong, AM
    Robinson, LA
    Steeber, DA
    Tedder, TF
    Yoshie, O
    Imai, T
    Patel, DD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1413 - 1419
  • [9] Foussat A, 2000, EUR J IMMUNOL, V30, P87, DOI 10.1002/1521-4141(200001)30:1<87::AID-IMMU87>3.0.CO
  • [10] 2-7